Anita Dushyanth
Stock Analyst at Berenberg
(2.75)
# 1,903
Out of 4,876 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $13.49 | +48.26% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $4.09 | +217.85% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.77 | +67,696.61% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $23.48 | +296.08% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $13.49
Upside: +48.26%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $4.09
Upside: +217.85%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.77
Upside: +67,696.61%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $23.48
Upside: +296.08%